
    
      This is a single center, randomized, double-blind, placebo controlled study. The study
      medication consists of L-citrulline and metformin, respectively placebo given orally; 2.5 g
      L-citrulline or placebo will be given 3 times daily, metformin containing 250 mg or placebo
      will be administered 3 times daily. The duration of the study is 26 weeks and comprehends one
      screening and three study visits.

      Amendment 1: Amended eligibility criteria
    
  